🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this observational study is to develop a machine learning model...
Status
Unknown
Location
Institut Guttmann
Start Date
2023-10-05
Trial ID
NCT06531317
Treatments Being Tested
Inter-individual variability in responsiveness to interventions poses great...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT03293316
Treatments Being Tested
This 4-week study will evaluate the safety and efficacy of crisaborole oint...
Status
Terminated
Location
Dermatology Trial Associates
Start Date
2018-04-27
Trial ID
NCT03539601
This study is being done to look at the combination of the drugs atezolizum...
Status
Withdrawn
Location
Princess Margaret Cancer Centre
Start Date
2021-07-16
Trial ID
NCT04510584
Treatments Being Tested
The purpose of the study is to evaluate differences in the time and costs b...
Status
Completed
Location
Florida Hospital
Start Date
2015-05
Trial ID
NCT02498821
Treatments Being Tested
Craniosacral exploration and therapy is one of the innovative palpation and...
Status
Completed
Location
Gema León Physiotherapy and Rehabilitation Clinic
Start Date
2021-12-18
Trial ID
NCT05340049
Treatments Being Tested
Parkinson's Disease (PD) is a neurodegenerative disorder characterized by m...
Status
Completed
Location
Hospital Beata Maria Ana
Start Date
2023-07-01
Trial ID
NCT06214377
Oral selexipag is commercially available in several countries for the treat...
Status
Terminated
Location
St. Vincent Medical Group, Inc.
Start Date
2021-02-26
Trial ID
NCT03942211
Primary objective: To evaluate the efficacy of tralokinumab compared with ...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2017-05-30
Trial ID
NCT03131648
Treatments Being Tested
The aim of this study was to describe the effect of direct IL-17A inhibitio...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-01-14
Trial ID
NCT03553823
Treatments Being Tested